FDA Approves First Therapy for Allergic Fungal Rhinosinusitis - Top-Institutions - MDSpire

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

  • By

  • Kathryn Wighton

  • February 25, 2026

  • 2 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Allergy and Immunology
    • Otolaryngology
    • Rhinology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Otolaryngology
    • Allergy and Immunology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Otolaryngology
    • Allergy and Immunology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Otolaryngology
    • Allergy and Immunology

Original Source(s)

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

  • by Kathryn Wighton

  • February 25, 2026

Related Content

Climate Vulnerability and Cardiometabolic Health Among Children

Autologous pericardial vs. pulmonary artery patches for infant aortic arch reconstruction: clinical and computational morphological outcomes

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.